|
1. Ksiazek T.G,, ERdman D., Goldsmith C.S., Zaki S.R., Peret T., Emery S., Tong S., Urbani C., Comer J.A., Lim W., Rollin P.E., Dowell S.F., Ling A.E., Humphrey C.D., Shieh W.J., Guarner J., Paddock C.D., Rota P., Fields B., DeRisi J., Yang J.Y., Cox N., Hughes J.M., LeDuc J.W., Bellini W.J., Anderson L.J., SARS Working Group. (2003) A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348:1953-1966. 2. Peiris J.S., Lai S.T., Poon L.L., Guan Y., Yam L.Y., Lim W., Nichols J., Yee W.K., Yan W.W., Cheung M.T., Cheng V.C., Chan K.H., Tsang D.N., Yung R.W., Ng T.K., Yuen K.Y., SARS Study Group. (2003) Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361:1319-1325. 3. Drosten C., Chiu L.L., Panning M, Leong H.N., Presier W., Tam J.S., Gunther S. Kramme S. Emmerich P., Ng W.L. Schmitz H., Koay E.S. (2004) Evaluation of advanced reverse transcription-PCR assays and an alternative PCR target region for detection of severe acute respiratory syndrome-associated coronavirus. J Clin Microbiol. 42(5): 2043-2047 4. Huang L.R., Chiu C.M., Yeh S.H., Huang W.H., Hsueh P.R., Yang W.Z., Yang J.Y., Su I.J., Chang S.C., Chen P.J. (2004) Evaluation of antibody responses against SARS coronaviral nucleocaosid or spike proteins by immunobloting or ELISA. J Med Virol. 73(3): 338-346. 5. Xu Y.D., Li Y.M., Liu X.Q., Chen S.B., He W.Q., Xiao Z.L., Zhong N.S. (2003) Clinical therapy of severe acute respiratory syndrome: 38 case retrospective analysis. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 15(6): 343-345 6. Tyrrel, D.A. J., J.D. Almedia, D.M. Berry, et al. (1968) Coronavirus. Nature 220:650. 7. Spaan, W., D. Cavanagh, M.C. Horzinek. (1988) Coronaviruses: structure and genome expression. J. Gen. Virol. 69(pt 12): 2939-2952. 8. Sturman, L.S., and K.V. Holmes. 1983. The molecular biology of coronaviruses. Adv. Virus Res. 28:35-112. 9. Bos E.C.W., Luytjes W., van der Meulen H., Koerten H.K., Spaan W.J.M.. (1996) The production of recombinant infectious DI-particle of a murine coronavirus in the absence of helper virus. Virology 218:52-60. 10. Vennema, H., G. J. Godeke, J. W. A. Rossen, W. F. Voorhout, M. C. Horzinek, D. J. E. Opstelten, P.J. M. Rottier. (1996) Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes. EMBO J. 15:2020-2028. 11. Lai M.M.C. (2003) SARS virus: the beginning of the unraveling of a new coronavirus. J. Biomed. Sci.10: 664-675. 12. Sonia N.M, Weiss S.R. (2003) SARS: lessons learned from other coronaviruses.Viral Immunol. 16:461-474 13. Marra M.A., Jones S.J., Astell C.R., Holt R.A., Brooks-Wilson A., Butterfield Y.S., Khattra J., Asaon J.K., Barber S.A., Chan S.Y., Cloutier A., Coughlin S.M., Freeman D., Girn N., Griffith O.L., Leach S.R., Mayo M., McDonald H., Montgomery S.B., Pandoh P.K., Petrescu A.S., Robertson A.G., Schein J.E., Siddiqui A., Smailus D.E., Stott J.M., Yang G.S., Plummer F., Andonov A., Artsob H., Bastien N., Bernard K., Booth T.F., Bowness D., Czub M., Drebot M., Fernando L., Flick R., Garbutt M., Gray M., Grolla A., Jones S., Feldmann H., Meyers A., Kabani A., Li Y., Normand S., Stroher U., Tipples G.A., Tyler S., Vogrig R., Ward D., Watson B., Brunham R.C., Krajden M., Petric M., Skowronski D.M., Upton C., Roper R.L.. The genome sequence of the SARS-associated coronavirus. (2003) Science 300:1399-1404. 14. Rota P.A., Oberste M.S., Monroe S.S., Nix W.A., Campagnoli R., Icenogle J.P., Penaranda S., Bankamp B., Maher K., Chen M.H., Tong S., Tamin A., Lowe L., Frace M., DeRisi J.L., Chen Q., Wang D., Erdmann D.D., Peret T.C., Burns C., Ksiazek T.G., Rollin P.E., Sanchez A., Liffick S., Holloway B., Limor J., McCaustland K., Olsen-Rasmussen M., Fouchier R., Gunther S., Osterhaus A.D., Drosten C., Pallansch M.A., Anderson L.J., Bellini W.J. (2003) Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300:1394-1399. 15. Snijder E.J., Bredenbeek P.J., Dobbe J.C., Thiel V., Ziebuhr J, Poon L.L., Guan Y, Rozanov M., Spaan W.J., Gorbalenya A.E. (2003) Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol. 331(5):991-1004. 16. Zhu G., Chen H.W. (2004) Monophyletic relationship between severe acute respiratory syndrome coronavirus and group 2 coronaviruses. J Infect Dis. 189(9):1676-1678. 17. Gibbs A.J., Gibbs M.J., Armstrong J.S. (2004) The phylogeny of SARS coronavirus. Arch Virol. 149(3):621-624. 18. DE Haan C.A.M., Kuo L.L., Masters P., VenneMa H., Rottier P.J.M. (1998) Coronavirus particle assembly: primary structure requirements of the membrane protein. J. Virol. 72: 6838-6850. 19. Kuo L.L., Masters P.S. (2002) Genetic Evidence for a structural interaction between the carboxy termini of the membrane and nucleocapsid proteins of mouse hepatitis virus. J. Virol. 76: 4987-4999. 20. Nuemann H., B. Boschek, D. Evans, M. Rosing, T. Tamura, H. D. Klenk. (1982) Post-translational glycosylation of coronavirus glycoprotein E1: inhibition by monensin. EMBO J.1:1499-1504. 21. Stern, D. F., B. M. Sefton. (1982) Coronavirus proteins: structure and function of the oligosaccharides of the avian infectious bronchitis virus glycoproteins. J. Virol. 44:804-812. 22. Laude, H., J. Gelfi, L. Lavenant, et al. (1992) Single amino acid changes in the viral glycoprotein M affect induction of alpha interferon by the coronavirus transmissible gastroenteritis virus. J. Virol. 66:743-749. 23. Charley, B., H. Laude. (1988) Induction of alpha interferon by transmissible gastroenteritis coronavirus: role of transmembrane glycoprotein E1. J. Virol. 62:8-11. 24. DE Haan C.A.M., de Wit, Kuo L., et al. (2002) O-glycosylation of the mouse hepatitis coronavirus membrane protein. Virus Res. 82:77-81. 25. Fuerst. T. R., E. G. Niles, F. W. Studier, B. Moss. (1986)Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 83:8122-8126 26. Lin Y.L., Liao C.L., Chen L.K., Yeh C.T., Liu C.I., Ma S.H., et al. (1998) Study of dengue virus infection in SCID mice engrafted with human K562 cells. J. Virol. 72: 9729-9737. 27. Ma H.C., Ke C.H., Hsieh T.Y., Lo S.Y. (2002) The first hydrophobic domain of the hepatitis C virus E1 protein is important for interaction with the capsid protein. J Gen Virol.83: 3085-3092. 28. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227:680-685. 29. Zhao Y, Mine Y, Ma C.Y. (2004) Study of thermal aggregation of oat globulin by laser light scattering. J Agric Food Chem. 52(10): 3089-3096. 30. Abu-Eid M, Kust S.V., Makeeva I.V., Novikov V.K., Dobrov E.N. (1994) Study of the process of thermal aggregation of several representative tobamovirus coat proteins. Mol Gen Mikrobiol Virusol. 3: 28-33. 31. Orlov V.N., Arutyunyan A.M., Kust S.V., Litmanovich E.A., Drachev V.A., Dobrov E.N. (2001) Macroscopic aggregation of tobacco mosaic virus coat protein. Biochemistry (Mosc). 66(2): 154-162 32. Lin H., Zhai J., Canete-Soler R., Schlaepfer W.W. (2004) 3’ untranslated region in a light neurofilament (NF-L) mRNA triggers aggregation of NF-L and mutant superoxide dismutase 1 proteins in neuronal cells. J Neurosci. 24(11): 2716-2726. 33. Tan Y.J., Goh P.Y., Fielding B.C., Shen S., Chou C.F., Fu J.L., Leong H.N., Leo Y.S., Ooi E.E., Ling A.E., Lim S.G., Hong W. (2004) Profile of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers. Clin. Diagn. Lab. Immunol. 11(2):362-371 34. Ho Y., Lin P.H., Liu C.Y.Y., Lee S.P., Chao Y.C. (2004) Assembly of human severe acute respiratory syndrome coronavirus-like particles. Biochem Biophys Res Commun. 318:833-838
|